← All compounds
metabolite40 listings
Rapamycin
Sirolimus / mTOR Inhibitor
mTOR inhibitor. Longevity research compound.
Longevity researchAutophagy research
/ research index
The research base
Research Maturity
★★★★★
5/5 — Volume of studies
Evidence Strength
★★★★★
5/5 — Quality of evidence
FDA approved. Extensive longevity research.
/ mechanism of action
How it works
mTOR inhibitor. Autophagy promotion.
/ research dosing
Common research protocols
Range
3-6 mg weekly (longevity protocol)
Frequency
Once weekly (pulsed)
Route
Oral on empty stomach
Cycle
Continuous weekly (Blagosklonny protocol) or 6-12 month courses
Research notes
Pulsed weekly dosing (3-6mg) reduces side effects vs daily transplant doses. Empty stomach absorption. Most common longevity research dose: 6mg/week. Monitor lipids, glucose, mTOR-related markers.
References
FOR RESEARCH USE ONLY. Doses listed are compiled from published research literature, FDA-approved drug labels, and well-documented research community practice. Not medical advice.
/ standalone use
As a solo compound
Solo use is standard.
/ side effects
What to know
Common: mouth sores, lipid changes at higher doses.
/ timeline
Realistic expectations
Long-term protocols
/ recommendation
Where to buy Rapamycin
🏆Our pick for Rapamycin
Modern Research Peptides
10mg · USA · Card / Crypto
- ✓Third-party tested (Janoshik)
- ✓COAs provided — Per-batch comprehensive
- ✓Highest verification tier in stock
- ✓4.8★ community rating
Also solid
/ all listings
Full index, price per mg
Supplier
Trust Score
Size
Price
$/mg
Stock
Buy
FOR RESEARCH USE ONLY. Rapamycin is intended for laboratory research and not for human consumption.